More on ARX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.71 |
|
|||
| Open | $11.76 | ||||
| 52 Wk High | $10.95 | ||||
| 52 Wk Low | $6.70 | ||||
| Day High | $11.76 | ||||
| Day Low | $11.14 | ||||
| P/E | N/A | ||||
| EPS | $-1.11 | ||||
| Volume | 969,172 | ||||
- Form 8-K Accelerant Holdings For: Feb 27
- Form 8-K Accelerant Holdings For: Feb 26
- Accelerant reports preliminary Q4 2025 revenue up 30% to $248 million
- Accelerant Announces Unaudited Preliminary Fourth Quarter and Full Year 2025 Financial Results
- Accelerant names Cliff Jenks general counsel, Ray Iardella investor relations head
- Accelerant Announces Leadership Updates Across Legal and Investor Relations
- Accelerant Holdings (ARX) PT Lowered to $13 at Piper Sandler
- Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call
- Form 4 Accelerant Holdings For: Feb 02 Filed by: Green Jay Michael
- Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
Entities mentioned with ARX
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Needham & Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Show More...
